| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |